Fingerprint
Dive into the research topics of 'HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: Implications for efficacy of'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: Implications for efficacy of
Adjuvant Trastuzumab, Suthinee Ithimakin, Kathleen C. Day, Fayaz Malik, Qin Zen, Scott J. Dawsey, Tom F. Bersano-Begey, Ahmed A. Quraishi, Kathleen Woods Ignatoski, Stephanie Daignault, April Davis, Christopher L. Hall, Nallasivam Palanisamy, Amber N. Heath, Nader Tawakkol, Tahra K. Luther, Shawn G. Clouthier, Whitney A. Chadwick, Mark L. Day, Celina G. Kleer
Research output: Contribution to journal › Article › peer-review
203
Scopus
citations